Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2.37	36.47	35.63
Graham Fair Price	48.77	17.00	11.42
PEG	-97.37	0.06	2.28
Price/Book	8.99	4.18	3.83
Price/Cash Flow	52.95	60.23	39.38
Prices/Earnings	-38.71	5.90	9.63
Price/Sales	17.71	15.23	12.94
Price/FCF	52.95	60.23	39.38
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.58	0.55	0.53
Operating Margin	8.61	0.46	0.42
ROA	101.99	0.05	0.02
ROE	0.10	0.18	77.82
ROIC	0.03	0.04	14.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	0.10	-24.20
Dividends QOQ	0.02	< 0.005	-93.38
EBIT QOQ	< 0.005	0.12	2924.04
EPS QOQ	0.04	0.99	2234.68
FCF QOQ	0.46	-0.20	-55.84
Revenue QOQ	0.11	0.03	-67.52
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.57	0.60	5.56
Days Sales Outstanding (DSO)	71.45	74.74	4.61
Inventory Turnover	158.94	150.57	-5.27
Debt/Capitalization	0.73	0.69	-5.06
Quick Ratio	0.73	1.46	99.28
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.63	8.52	11.57
Cash	0.72	0.78	8.09
Capex	-0.52	-0.51	2.37
Free Cash Flow	0.74	0.59	-20.50
Revenue	2.26	2.34	3.30
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.76	1.51	97.87
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.58	12.54	-13.97
Naive Interpretation	Member

06 - Financial Health · Weak

Rating